PT3083997T - Utilizações diagnósticas, prognósticas e terapêuticas de rnas longos não codificadores para doenças cardíacas e medicina regenerativa - Google Patents
Utilizações diagnósticas, prognósticas e terapêuticas de rnas longos não codificadores para doenças cardíacas e medicina regenerativaInfo
- Publication number
- PT3083997T PT3083997T PT148284565T PT14828456T PT3083997T PT 3083997 T PT3083997 T PT 3083997T PT 148284565 T PT148284565 T PT 148284565T PT 14828456 T PT14828456 T PT 14828456T PT 3083997 T PT3083997 T PT 3083997T
- Authority
- PT
- Portugal
- Prior art keywords
- prognostic
- diagnostic
- heart disease
- therapeutic uses
- regenerative medicine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361964591P | 2013-12-20 | 2013-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3083997T true PT3083997T (pt) | 2020-11-03 |
Family
ID=52394217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT148284565T PT3083997T (pt) | 2013-12-20 | 2014-12-19 | Utilizações diagnósticas, prognósticas e terapêuticas de rnas longos não codificadores para doenças cardíacas e medicina regenerativa |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11193171B2 (pt) |
| EP (2) | EP3825419A3 (pt) |
| DK (1) | DK3083997T3 (pt) |
| ES (1) | ES2837437T3 (pt) |
| HU (1) | HUE051159T2 (pt) |
| IL (3) | IL285107B2 (pt) |
| PL (1) | PL3083997T3 (pt) |
| PT (1) | PT3083997T (pt) |
| SI (1) | SI3083997T1 (pt) |
| WO (1) | WO2015092020A2 (pt) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11660317B2 (en) | 2004-11-08 | 2023-05-30 | The Johns Hopkins University | Compositions comprising cardiosphere-derived cells for use in cell therapy |
| EP3563859B1 (en) | 2012-08-13 | 2021-10-13 | Cedars-Sinai Medical Center | Cardiosphere-derived exosomes for tissue regeneration |
| JP6878274B2 (ja) | 2014-10-03 | 2021-05-26 | シーダーズ−サイナイ・メディカル・センターＣｅｄａｒｓ−Ｓｉｎａｉ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ | 筋ジストロフィーの処置における心筋球由来細胞およびこのような細胞によって分泌されたエキソソーム |
| WO2017123662A1 (en) | 2016-01-11 | 2017-07-20 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction |
| CN105802969A (zh) * | 2016-05-10 | 2016-07-27 | 新疆医科大学第附属医院 | lncRNA ENST00000581794.1及制剂或诊断剂或药物或试剂盒和应用 |
| WO2017210652A1 (en) | 2016-06-03 | 2017-12-07 | Cedars-Sinai Medical Center | Cdc-derived exosomes for treatment of ventricular tachyarrythmias |
| CN107460234B (zh) * | 2016-06-06 | 2020-06-16 | 王辉云 | 血清48-lncRNA作为肝脏慢性疾病诊断标记物的应用 |
| US20200181703A1 (en) * | 2016-07-07 | 2020-06-11 | Siemens Healthcare Gmbh | Epigenome-wide association study identifies cardiac developmental gene patterning and a novel class of biomarkers for heart failure |
| US11541078B2 (en) | 2016-09-20 | 2023-01-03 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders |
| WO2018191536A1 (en) * | 2017-04-13 | 2018-10-18 | Chi-Hua Foundation | Method for prognosing adverse cardiovascular outcome in patients with coronary artery diseases |
| US20190127795A1 (en) * | 2017-04-13 | 2019-05-02 | Tiffany Wu | Method for prognosing and reducing cardiovascular disease in patients with kidney diseases |
| US11759482B2 (en) | 2017-04-19 | 2023-09-19 | Cedars-Sinai Medical Center | Methods and compositions for treating skeletal muscular dystrophy |
| WO2018229046A1 (en) | 2017-06-12 | 2018-12-20 | Firalis Sa | DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC USES OF LONG NONCODING RNAs FOR PATHOLOGIES AND TOXICITIES INDUCING HEART DISORDERS |
| CA3067910A1 (en) * | 2017-06-19 | 2018-12-27 | Universite De Lausanne | Methods and compositions for controlling cardiac fibrosis and remodeling |
| US11708600B2 (en) * | 2017-10-05 | 2023-07-25 | Decode Health, Inc. | Long non-coding RNA gene expression signatures in disease diagnosis |
| US11660355B2 (en) | 2017-12-20 | 2023-05-30 | Cedars-Sinai Medical Center | Engineered extracellular vesicles for enhanced tissue delivery |
| CN107948321B (zh) * | 2017-12-29 | 2021-10-12 | 威马智慧出行科技（上海）有限公司 | 车辆的远程授权方法及系统 |
| CN108148908B (zh) * | 2018-03-16 | 2020-05-12 | 中国人民解放军沈阳军区总医院 | 动脉粥样硬化性肾动脉狭窄诊断分子标记物的应用 |
| CN110396542A (zh) * | 2019-05-20 | 2019-11-01 | 徐州市疾病预防控制中心(徐州市健康教育所) | 一种LncRNA标记物及其在糖尿病中的应用 |
| AU2021275327A1 (en) * | 2020-05-19 | 2022-12-08 | Cedars-Sinai Medical Center | Exosome-derived PIWI-interacting RNA and methods of use thereof |
| CN112176053B (zh) * | 2020-10-12 | 2021-06-25 | 山东大学齐鲁医院(青岛) | 一种急性重症病毒性心肌炎基因标志物 |
| CN113388673B (zh) * | 2021-04-28 | 2022-09-20 | 广东省人民医院 | 长非编码rna carmen的应用 |
| KR102643120B1 (ko) * | 2021-11-12 | 2024-03-05 | 재단법인 아산사회복지재단 | 대동맥판막 협착증의 진단을 위한 미토콘드리아 바이오마커 및 미토콘드리아 활성화제를 포함하는 대동맥판막 협착증의 예방 또는 치료용 약학적 조성물 |
| WO2024003205A1 (en) * | 2022-06-30 | 2024-01-04 | Medizinische Hochschule Hannover | Long non-coding rnas as target for treating fibrosis and cancer |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5118937A (en) | 1989-08-22 | 1992-06-02 | Finnigan Mat Gmbh | Process and device for the laser desorption of an analyte molecular ions, especially of biomolecules |
| US5545522A (en) | 1989-09-22 | 1996-08-13 | Van Gelder; Russell N. | Process for amplifying a target polynucleotide sequence using a single primer-promoter complex |
| US5045694A (en) | 1989-09-27 | 1991-09-03 | The Rockefeller University | Instrument and method for the laser desorption of ions in mass spectrometry |
| CA2163426C (en) | 1993-05-28 | 2005-11-01 | T. William Hutchens | Method and apparatus for desorption and ionization of analytes |
| US5578832A (en) | 1994-09-02 | 1996-11-26 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
| US5539083A (en) | 1994-02-23 | 1996-07-23 | Isis Pharmaceuticals, Inc. | Peptide nucleic acid combinatorial libraries and improved methods of synthesis |
| US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
| US6028189A (en) | 1997-03-20 | 2000-02-22 | University Of Washington | Solvent for oligonucleotide synthesis and methods of use |
| NZ516848A (en) | 1997-06-20 | 2004-03-26 | Ciphergen Biosystems Inc | Retentate chromatography apparatus with applications in biology and medicine |
| US7013221B1 (en) | 1999-07-16 | 2006-03-14 | Rosetta Inpharmatics Llc | Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays |
| CA2531967C (en) | 2003-07-10 | 2013-07-16 | Genomic Health, Inc. | Expression profile algorithm and test for cancer prognosis |
| US7312035B2 (en) * | 2004-09-03 | 2007-12-25 | Affymetrix, Inc. | Methods of genetic analysis of yeast |
| JP2014501489A (ja) | 2009-07-06 | 2014-01-23 | アルナイラム ファーマシューティカルズ， インコーポレイテッド | 細胞ベースのバイオプロセシング |
| WO2015031694A2 (en) * | 2013-08-28 | 2015-03-05 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
-
2014
- 2014-12-19 HU HUE14828456A patent/HUE051159T2/hu unknown
- 2014-12-19 ES ES14828456T patent/ES2837437T3/es active Active
- 2014-12-19 DK DK14828456.5T patent/DK3083997T3/da active
- 2014-12-19 US US15/105,319 patent/US11193171B2/en active Active
- 2014-12-19 SI SI201431696T patent/SI3083997T1/sl unknown
- 2014-12-19 EP EP20176907.2A patent/EP3825419A3/en active Pending
- 2014-12-19 PL PL14828456T patent/PL3083997T3/pl unknown
- 2014-12-19 IL IL285107A patent/IL285107B2/en unknown
- 2014-12-19 PT PT148284565T patent/PT3083997T/pt unknown
- 2014-12-19 EP EP14828456.5A patent/EP3083997B1/en active Active
- 2014-12-19 WO PCT/EP2014/078868 patent/WO2015092020A2/en active Application Filing
-
2016
- 2016-06-08 IL IL246103A patent/IL246103B/en active IP Right Grant
-
2020
- 2020-01-23 IL IL272226A patent/IL272226B/en unknown
-
2021
- 2021-10-19 US US17/505,153 patent/US20220136054A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3825419A2 (en) | 2021-05-26 |
| US20220136054A1 (en) | 2022-05-05 |
| SI3083997T1 (sl) | 2020-12-31 |
| DK3083997T3 (da) | 2020-10-19 |
| EP3825419A3 (en) | 2021-09-15 |
| IL246103B (en) | 2020-02-27 |
| IL285107B1 (en) | 2023-10-01 |
| PL3083997T3 (pl) | 2021-04-06 |
| IL285107B2 (en) | 2024-02-01 |
| HUE051159T2 (hu) | 2021-03-01 |
| IL285107A (en) | 2021-08-31 |
| IL272226B (en) | 2021-08-31 |
| EP3083997A2 (en) | 2016-10-26 |
| WO2015092020A2 (en) | 2015-06-25 |
| IL272226A (en) | 2020-03-31 |
| EP3083997B1 (en) | 2020-07-29 |
| ES2837437T3 (es) | 2021-06-30 |
| IL246103A0 (en) | 2016-07-31 |
| WO2015092020A3 (en) | 2015-09-24 |
| US20160312283A1 (en) | 2016-10-27 |
| US11193171B2 (en) | 2021-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285107A (en) | Diagnostic, prognostic and therapeutic uses of long non-coding RNA molecules for heart diseases and rehabilitation medicine | |
| HK1224390A1 (zh) | 報告對處置方案的依從性的患者護理系統 | |
| IL242825B (en) | Systems and methods for diagnosis of depression and other medical conditions | |
| IL243408A0 (en) | Diagnosis and treatment of cancer involving cancer stem cells | |
| HK1217088A1 (zh) | 微泡在醫學疾病和病况的診斷、預後和治療中的用途 | |
| EP2849632A4 (en) | CLINICAL DIAGNOSTIC SYSTEM WITH INSTRUMENT AND CARTRIDGE | |
| EP2967484A4 (en) | SYSTEM AND SIGNATURES FOR MULTIMODAL PHYSIOLOGICAL STIMULATION AND EVALUATION OF BRAIN HEALTH | |
| EP2971127A4 (en) | DIAGNOSTIC AND TREATMENT METHODS FOR INFLAMMATORY INTESTINAL DISEASE | |
| EP2868096A4 (en) | DEVICES, METHODS AND SYSTEMS FOR COLLECTING MEDICAL DIAGNOSTIC INFORMATION AND PROVIDING TELECOMMUNICATIONS SERVICES | |
| PL3010660T3 (pl) | Urządzenie do przestrzegania zaleceń medycznych dla pacjenta | |
| EP2965778A4 (en) | MEDICAL INSTRUMENT, CATHETER AND METHOD FOR PRODUCING A MEDICAL INSTRUMENT | |
| HK1197987A1 (zh) | 用於測量人體部位動作的數據設備及其對應的系統 | |
| DK2964088T3 (da) | Vaginalt lægemiddeladministrations- og/eller diagnosesystem | |
| EP2875158A4 (en) | USE OF MICROVESICLES IN THE DIAGNOSIS, FORECAST AND TREATMENT OF DISEASES AND MEDICAL SUDDEN | |
| IL275368B (en) | Diagnosis and treatment of autoimmune diseases | |
| HK1214526A1 (zh) | 眼底疾病治療劑 | |
| LTPA2020511I1 (lt) | Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui | |
| EP2974751A4 (en) | SPHERROID CARDIAC OR VASCULAR TISSUE | |
| EP2888370A4 (en) | DIAGNOSIS, FORECASTING AND TREATMENT PROCEDURES | |
| HK1214752A1 (zh) | 由產甲烷菌引起或與之相關的疾病及病狀的診斷、選擇及治療方法 | |
| EP3013425A4 (en) | Treatment and diagnosis of ocular disease | |
| EP2934285A4 (en) | METHOD AND SYSTEMS FOR DIAGNOSIS OF EYE DISEASES | |
| EP2984170A4 (en) | USE OF ANTIBODY UREASE CONJUGATES FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES | |
| GB201309645D0 (en) | Treatment of peripheral arterial disease and other conditions, and apparatus therefor | |
| EP2943593A4 (en) | DIAGNOSIS AND TREATMENT OF VIRUS DISEASES |